Publication: 3075

Publication: 3075

CALGB 90601 (Alliance): Randomized, double blind, placebo-controlled phase III trial comparing gemcitabine and cisplatin with bevacizumab or placebo in patients with metastatic urothelial carcinoma

URL

Google Scholar

Citation:: J Clin Oncol vol 37 (15 suppl) abst 4503

Meeting Instance:: ASCO 2019
Year:: 2019
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: Yes

Parents:: None
Children:: 3485

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: Genentech
Grants:: U10CA180821, U10CA180882; U10CA180820 (ECOG-ACRIN); U10CA180853, U10CA180888 (SWOG)

Corr. Author:
Authors:: Jonathan Rosenberg Karla Ballman Susan Halabi Colleen Watt Olwen Mary Hahn Preston D. Steen Hahn Olwen Dreicer Robert Thomas Flaig Walter Stadler Christopher Sweeney Amir Mortazavi Michael Morris

Networks:: LAPS-CO070, LAPS-IL057, LAPS-MA036, LAPS-NY016, LAPS-OH007, SANFORD, VA002

Study: CALGB-90601
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: